Inventor · disambiguated record
Sauveur-Michel Maira
Also filed as: MAIRA SAUVEUR-MICHEL
4 granted patents·17 pending applications·42 citations·filing 2001–2018
71Inventor score
Top patents by PatentIndex Score
21 records- 0183US9370508B2Imidazoquinolines as dual lipid kinase and mTOR inhibitorsGARCIA-ECHEVERRIA CARLOS·Filed 2008·Granted Jun 21, 2016·13 cites·1 claims
- 0282US7396920B2Tumour suppressor and uses thereofNOVARTIS FORSCHUNGSSTIFTUNG·Filed 2001·Granted Jul 8, 2008·29 cites·5 claims
- 0362US2011195966A1Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorNOVARTIS AG·Filed 2009·Application pending·0 cites
- 0459US2009069394A1Cancer treatment with epothilonesDILEA CLIFFORD·Filed 2008·Application pending·0 cites
- 0556US2011105521A1Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathwayNOVARTIS AG·Filed 2009·Application pending·0 cites
- 0655US2018325883A1Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family membersNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0754US9241939B2Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathwayGARCIA-ECHEVERRIA CARLOS·Filed 2014·Granted Jan 26, 2016·0 cites·4 claims
- 0852US2018133226A1Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0951US2018085362A1Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1049US2008214596A1Biomarkers for sensitivity of proliferative diseases to mtor inhibitorsBOULAY ANNE·Filed 2008·Application pending·0 cites
- 1148US2013209461A1Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family membersBRACHMANN SASKIA MARIA·Filed 2011·Application pending·0 cites
- 1247US2010196365A1Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family membersNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1347US2014057904A1Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathwayGARCIA-ECHEVERRIA CARLOS·Filed 2013·Application pending·0 cites
- 1445US2016136175A1Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorGARCIA-ECHEVERRIA CARLOS·Filed 2015·Application pending·0 cites
- 1544US2015250778A1Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family membersBRACHMANN SASKIA MARIA·Filed 2015·Application pending·0 cites
- 1644US2007167478A1Biomarkers for sensitivity of proliferative diseases to mtor inhibitorsBOULAY ANNE·Filed 2004·Application pending·0 cites
- 1743US2014066474A1Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorFRITSCH CHRISTINE·Filed 2012·Application pending·0 cites
- 1842US2006235059A1Cancer treatment with epothilonesDILEA CLIFFORD·Filed 2004·Application pending·0 cites
- 1942US2017095463A1Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorFRITSCH CHRISTINE·Filed 2016·Application pending·0 cites
- 2041US9795596B2Pharmaceutical diagnosticFURET PASCAL·Filed 2013·Granted Oct 24, 2017·0 cites·2 claims
- 2132US2012059005A1Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseasesBASELGA JOSE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sauveur-Michel Maira files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →